A B S T R A C T In previous clinical studies with highly purified porcine luteinizing hormone-releasing hormone (LH-RH), administration of the somewhat arbitrarily chosen doses of 700-1500 jg resulted in increased serum levels of luteinizing hormone (LH) and follicle-stimulating hormone (FSH). 
INTRODUCTION
Three studies have been reported in which highly purified porcine luteinizing hormone-releasing hormone (LH-RH)1 has been administered to human beings (1) (2) (3) . The primary purpose of these previous investigations was gland of man in a number of clinical and experimental conditions. A single dose of LH-RH was used in these tests. This amount, 700-1500 lg, was calculated on the basis of results obtained from experiments in animals (4-6) and was chosen so as to be reasonably sure of giving an adequate response.
The present study was designed to determine the minimum effective dose of this highly purified preparation of porcine LH-RH in releasing LH in man. At the same time, it was ascertained whether a linear log doseresponse relationship of serum LH to the administered LH-RH could be demonstrated.
METHODS
The LH-RH used in this study was the same as that employed in the other clinical studies with porcine LH-RH (1-3). Its preparation from acetic acid extracts of porcine hypothalami was described previously (6, 7) and consisted of gel filtration on Sephadex G-25 columns, followed by concentration with phenol, chromatography, and rechromatography on carboxymethylcellulose columns, free-flow electrophoresis, and counter-current distribution. The fraction utilized for this study stimulated LH release in ovariectomized rats pretreated with estrogen and progesterone at doses of 10 ng; it was 10-15 times less potent than our most highly purified preparation of LH-RH (8) .
Three normal men, 30-33 yr old, received a single i.v. injection of LH-RH at intervals of at least 1 wk. The material was dissolved in 0.1 M acetic acid and diluted with saline. The following doses were used: 1.1, 3.3, 10, 30, 90, 270, and 810 rug. No side effects whatsoever were noted. Informed, written consent was obtained from all subj ects.
Blood was taken from an indwelling i.v. catheter immediately before injection of LH-RH (time 0), and 8, 16, 32, 64, and 128 min later. After centrifugation, the serum was separated and frozen. Serum LH and follicle-stimulating hormone (FSH) levels were measured by specific radioimmunoassays (9, 10) A highly significant (P < 0.01) linear trend in the log dose-response curve was observed for both LH and FSH after administration of LH-RH. This is illustrated for LH in Fig. 1 at the times of maximum response, which usually occurred at 16 min (Table I) .
In addition to there being statistically significant differences in serum LH and FSH at various times and at various doses, there was a significant difference in the responses of the individual subjects (subject-dose interaction, subject-time interaction). One of the men, in particular, showed consistently low responses to each dose of LH-RH. The statistical tests used in these analyses were based upon a pooled estimate of the error term. This estimate is the best measurement of individual variability and is obtained by adjustment of the total variation by all known sources of variation.
DOSE LH-RH (Ag) FIGURE 1 Maximum mean responses of plasma LH levels (mIU/ml) in three normal men to porcine LH-RH. The SEM at each point is 1.35 mIU/ml. This was derived from the residual mean square after analysis of variance. DISCUSSION Previous studies have demonstrated that administration of 700-1500 lxg of porcine LH-RH results in elevation of serum LH values in the human being (1) (2) (3) . In the present study, the smallest dose of LH-RH which increased serum LH in the three normal men to a level significantly different from that obtained before injection was 10 iyg. This is equivalent to less than 1 ug of our most highly purified porcine LH-RH. At this 10 FSH-RH activity of the most highly purified preparations of porcine LH-RH is intrinsic to LH-RH rather than due to contamination with FSH-RH (6, 8, 11, 12) . The present study again demonstrates that in humans, also, LH-RH releases FSH as well as LH (1-3). It does not cause consistent changes in the plasma levels of growth hormone, thyrotropin, or cortisol (13) .
The linear trend to the log dose-response curve was highly significant (P < 0.01). The maximum response of serum LH to each dose of LH-RH has been selected to illustrate this point in Fig. 1 . Therefore, in man as in the rat (6) (7) (8) , LH-RH behaves in a manner similar to other hormones, exhibiting a linear log dose-response curve. Significant LH release can be obtained with doses of LH-RH much smaller than those used previously.
